Wolverine Trading’s Co-Diagnostics CODX Stock Holding History

Wolverine Trading’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-451	Closed	-$9.46K	–	4876
2024 Q4	$9.46K	Buy	+451	New	+$14.2K	﹤0.01%	5162
2024 Q3	–	Sell	-742	Closed	-$27.8K	–	4849
2024 Q2	$27.8K	Buy	+742	New	+$27K	﹤0.01%	4297
2021 Q4	–	Sell	-850	Closed	-$223K	–	6009
2021 Q3	$248K	Sell	850 -104	-11%	-$30.4K	﹤0.01%	5000
2021 Q2	$255K	Sell	954 -14	-1%	-$3.6K	﹤0.01%	4669
2021 Q1	$248K	Buy	968 +217	+29%	+$86.6K	﹤0.01%	4732
2020 Q4	$219K	Buy	751 +29	+4%	+$10.7K	﹤0.01%	4114
2020 Q3	$302K	Buy	722 +347	+93%	+$178K	﹤0.01%	3394
2020 Q2	$196K	Buy	+375	New	+$171K	﹤0.01%	3840

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAG

Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Wolverine Trading's CODX Position: Q1 2025 in Review

Wolverine Trading sold out of Co-Diagnostics (CODX) in Q1 2025, closing a stake of 451 shares — an estimated $9.46K sold.

Wolverine Trading first reported a position in CODX in Q2 2020 and held it in 8 quarters. The position peaked at $302K in Q3 2020. 38 funds tracked by Wall St. Rank hold CODX as of Q1 2025.

Wolverine Trading reported no remaining Co-Diagnostics position as of Q1 2025 after selling out during the quarter.
Wolverine Trading sold 451 Co-Diagnostics shares in Q1 2025, an estimated $9.46K.
Wolverine Trading first reported a position in Co-Diagnostics in Q2 2020 and held it in 8 quarters.
Wolverine Trading's Co-Diagnostics position peaked at $302K in Q3 2020.
38 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.